OTC Markets OTCPK - Delayed Quote USD

Aptose Biosciences Inc. (APTOF)

1.6500
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
26,257
26,257
52,356
42,602
65,447
Operating Income
-26,257
-26,257
-52,356
-42,602
-65,447
Net Non Operating Interest Income Expense
150
150
1,151
788
94
Other Income Expense
677
677
-2
-9
-1
Pretax Income
-25,430
-25,430
-51,207
-41,823
-65,354
Net Income Common Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Diluted NI Available to Com Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Basic EPS
-87.60
-36.38
-227.43
-204.00
-328.50
Diluted EPS
-87.60
-36.38
-227.43
-204.00
-328.50
Basic Average Shares
468.0660
698.9790
225.1540
205.0330
197.9680
Diluted Average Shares
468.0660
698.9790
225.1540
205.0330
197.9680
Total Expenses
26,257
26,257
52,356
42,602
65,447
Net Income from Continuing & Discontinued Operation
-25,430
-25,430
-51,207
-41,823
-65,354
Normalized Income
-26,107
-26,107
-51,205
-41,814
-65,353
Interest Income
357
357
1,151
788
94
Interest Expense
207
207
0
--
--
Net Interest Income
150
150
1,151
788
94
EBIT
-25,223
-25,223
-51,207
-42,602
-65,447
EBITDA
-24,819
-24,819
-50,741
-42,074
-64,825
Reconciled Depreciation
404
404
466
528
622
Net Income from Continuing Operation Net Minority Interest
-25,430
-25,430
-51,207
-41,823
-65,354
Total Unusual Items Excluding Goodwill
677
677
-2
-9
-1
Total Unusual Items
677
677
-2
-9
-1
Normalized EBITDA
-25,496
-25,496
-50,739
-42,065
-64,824
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/16/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RNTX Rein Therapeutics Inc.
1.7600
+1.15%
 
PHGE BiomX Inc.
0.5160
-7.38%
 
ELTX Elicio Therapeutics, Inc.
5.49
-1.44%
 
ENTO Entero Therapeutics, Inc.
0.4190
+5.09%
 
PMCB PharmaCyte Biotech, Inc.
1.1100
+1.83%
 
GLTO Galecto, Inc.
2.7450
-1.96%
 
ORGS Orgenesis Inc.
2.0800
+9.47%
 
APM Aptorum Group Limited
0.8609
-3.81%
 
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
 
BOLT Bolt Biotherapeutics, Inc.
0.3580
-3.24%